Nontoxic effects of thymol, carvacrol, cinnamaldehyde, and garlic oil on dung beetles: A potential alternative to ecotoxic anthelmintics

The sustainability of the traditional extensive livestock sector will only be possible if healthy dung-decomposing insect communities are preserved. However, many current pharmaceutical anthelmintics are harmful to dung beetles, their presence can have a negative impact on biological systems. Phytochemical anthelmintics are an alternative to ecotoxic synthetic pharmaceutical anthelmintics, although ecotoxicological tests of their possible indirect effects on dung beetles are required to demonstrate their viability. In this study, the potential ecotoxicity of thymol, carvacrol, cinnamaldehyde and garlic oil (diallyl disulfide and diallyl trisulfide) were tested for the first time. Inhibition of antennal response was measured as a relevant parameter by obtaining relevant toxicity thresholds derived from concentration‒response curves, such as the IC50. All phytochemical compounds tested were demonstrated to be suitable alternative candidates to the highly ecotoxic compound ivermectin, considering their non-toxicity to nontarget organisms. Residues of the phytochemical antiparasitics found in cattle droppings were extremely low, even undetectable in the case of diallyl disulfide and diallyl trisulfide. Furthermore, our results showed that none of the phytochemical compounds have ecotoxic effects, even at extremely high concentrations, including those almost 1000 times higher than what is most likely to be found in dung susceptible to ingestion by dung beetles in the field. We can conclude that the four selected phytochemical compounds meet the requirements to be considered reliable alternatives to ecotoxic veterinary medicinal products, such as ivermectin.

Links Between Feeding Preferences and Electroantennogram Response Profiles in Dung Beetles: The Importance of Dung Odor Bouquets

The detection of dung odors is a crucial step in the food-searching behavior of dung beetles (Coleoptera: Scarabaeoidea). Yet, whether certain compounds characteristic of a given dung type contribute to a ‘choosy generalism’ behavior proposed for this taxonomic group is unknown. To address this, we analyzed the chemical composition of three types of dung (cow, horse, and rabbit) and conducted behavioral and electroantennogram (EAG) bioassays on 15 species of dung beetles using 19 volatile organic compounds representing the three dung samples. Chemical analyses revealed substantial qualitative and quantitative differences among dung types. When offered these food options in an olfactometer, 14 species exhibited a feeding preference. Surprisingly, all 19 compounds used in the EAG assays elicited antennal responses, with species displaying different olfactory profiles. The relationship between behavioral preferences and electrophysiological profiles highlighted that species with different food preferences had differences in antennal responses. Moreover, a specific set of EAG-active compounds (nonanal, sabinene, acetophenone, ρ-cresol, 2-heptanone, 1H-indole, and 6-methyl-5-hepten-2-one) were the strongest drivers in the distinct sensory profiles of the trophic preference groups. Our results point to the importance of the whole bouquet of dung-emanating compounds in driving food-searching behavior, but specific volatiles could aid in determining highly marked trophic preferences in certain species.

First observation on the predation of a non-arthropod species by a dung beetle species: The case of Canthon chalybaeus and the snail Bulimulus apodemetes

We described, for the first time, a case of predation of a non-arthropod species by a dung beetle species. Canthon chalybaeus Blanchard, 1843 kills healthy individuals of the terrestrial snail Bulimulus apodemetes (D'Orbigny, 1835) showing an evident pattern of physical aggressiveness in the attacks using the dentate clypeus and the anterior tibiae. The description of this predatory behaviour was complemented with the analysis of the chemical secretions of the pygidial glands of C. chalybaeus, highlighting those main chemical compounds that, due to their potential toxicity, could contribute to death of the snail. We observed a high frequency of predatory interactions reinforcing the idea that predation in dung beetles is not accidental and although it is opportunistic it involves a series of behavioural sophistications that suggest an evolutionary pattern within Deltochilini that should not only be better studied from a behavioural point of view but also phylogenetically.

Biomagnification and body distribution of ivermectin in dung beetles

A terrestrial test system to investigate the biomagnification potential and tissue-specific distribution of ivermectin, a widely used parasiticide, in the non-target dung beetle Thorectes lusitanicus (Jekel) was developed and validated. Biomagnification kinetics of ivermectin in T. lusitanicus was investigated by following uptake, elimination, and distribution of the compound in dung beetles feeding on contaminated faeces. Results showed that ivermectin was biomagnified in adults of T. lusitanicus when exposed to non-lethal doses via food uptake. Ivermectin was quickly transferred from the gut to the haemolymph, generating a biomagnification factor (BMF_k) three times higher in the haemolymph than in the gut after an uptake period of 12 days. The fat body appeared to exert a major role on the biomagnification of ivermectin in the insect body, showing a BMF_k 1.6 times higher than in the haemolymph. The results of this study highlight that the biomagnification of ivermectin should be investigated from a global dung-based food web perspective and that the use of these antiparasitic substances should be monitored and controlled on a precautionary basis. Thus, we suggest that an additional effort be made in the development of standardised regulatory recommendations to guide biomagnification studies in terrestrial organisms, but also that it is necessary to adapt existing methods to assess the effects of such veterinary medical products.

Thermoregulatory syndromes of two sympatric dung beetles with low energy costs

In heterotherm insects, endothermy implies a high energy cost due to the generation and regulation of body temperature during different activities such as flight, food location, fighting and even walking. We studied the thermoregulation process and the cost of the thermoregulation strategies in two sympatric dung beetles, Sulcophanaeus batesi and S. imperator under heat and cold stress conditions. We used a set of physiological variables to exemplify the capacity of thermolimit respirometry combined with infrared thermography to derive relevant variables capable of describing different thermoregulation syndromes. Habitat use and thermal niche differed notably between S. batesi and S. imperator, reflecting their contrasted thermal requirements. In S. imperator, thermal specialization for high temperatures was observed, being active mainly during the warmer period of the day. On the other hand, thermal adaptation in S. batesi allows its preference for cold exhibiting a morning activity periods, avoiding higher temperatures. The thermophilic strategy used by Sulcophanaeus imperator minimized the energy expenditure produced during the cooling of the body by respiration without thereby endangering higher thermal limits. In this case, S. batesi, the species with a preference for the coldest environments, presented the lowest thermal limits, although the energy cost needed to stay active during cooling was significantly lower than that in S. imperator. Sulcophanaeus imperator and S. batesi showed evident 'economizing' strategies associated with hot and cold environmental conditions, respectively. In contrast, if both species experience a deviation from their thermal optimum, a decrement in their performance could be produced.

Ivermectin residues disrupt dung beetle diversity, soil properties and ecosystem functioning: An interdisciplinary field study

Ivermectin is the most common endectocide used to control parasites affecting livestock. Short-term physiological and behavioural effects of ivermectin on dung beetles may have long-term consequences for beetle populations and ecosystem functioning. Long-term effects of the use of ivermectin can be estimated by comparing dung assemblages and ecosystem functions in areas with conventional ivermectin-treated livestock and environmentally similar areas in which livestock are not treated with veterinary medical products (organic farming). In this study, we investigated both short-term and long-term effects of the administration of ivermectin on the characteristics of dung beetle assemblages and the services they provided in a protected area (Doñana National Park, SW Spain). We examined short-term dung colonization, dwelling, relocation, and disaggregation rates and the associations between these processes and the key assemblage parameters of species richness, abundance, biomass and functional diversity. Furthermore, we analysed changes in soil physical-chemical properties and processes. Short-term differences were observed in the total amount of dung relocated by dung beetles at different colonization vs. emigration stages, suggesting that dung beetles in this area were affected by the recent treatments of livestock with ivermectin. Moreover, short-term effects could also be responsible for the significant differences in dung spreading rates between sites. Conventional use of ivermectin disrupted ecosystem functioning by affecting species richness, abundance and biomass. The decrease in diversity parameters was related to a reduction in the functional efficiency, which resulted in the long-term accumulation of dung on the ground and considerable changes in soil functionality.

Isolation and determination of ivermectin in post-mortem and in vivo tissues of dung beetles using a continuous solid phase extraction method followed by LC-ESI+-MS/MS

A new analytical method based on solvent extraction, followed by continuous solid-phase extraction (SPE) clean-up using a polymeric sorbent, was demonstrated to be applicable for the detection of ivermectin in complex biological matrices of dung beetles (hemolymph, excreta or dry tissues) using liquid chromatography combined with positive electrospray ionization tandem mass spectrometry (LC/ESI⁺–MS/MS). Using a signal-to-noise ratio of 3:1, the limit of detection (LOD) in the insect matrices at trace levels was 0.01 ng g^–1 and the limit of quantification (LOQ) was 0.1 ng g^–1. The proposed method was successfully used to quantitatively determine the levels of ivermectin in the analysis of small samples in in vivo and post mortem samples, demonstrating the usefulness for quantitative analyses that are focused on future pharmacokinetic and bioavailability studies in insects and the establishment of a new protocol to study the impact of ivermectin on non-target arthropods such as dung beetles and other insects that are related with the “dung community”. Because satisfactory precision and accuracy values were obtained in both in vivo matrices, we suggest that the method can be consistently used for quantitative determinations that are focused on future pharmacokinetic and bioavailability studies in insects. Furthermore, this new analytical method was successfully applied to biological samples of dead dung beetles from the field suggesting that the method can be used to establish a new routine analysis of ivermectin residues in insect carcasses that is applied to complement typical mortality tests.

Identification and evaluation of semiochemicals for the biological control of the beetle Omorgus suberosus (F.) (Coleoptera: Trogidae), a facultative predator of eggs of the sea turtle Lepidochelys olivacea (Eschscholtz)

The beetle Omorgus suberosus (F.) is a facultative predator of eggs of the olive ridley turtle Lepidochelys olivacea (Eschscholtz). Laboratory and field investigations were conducted in order to characterize volatile attractants of O. suberosus and to explore the potential for application of these volatiles in a selective mass trapping method. Headspace sorptive extraction (HSSE) coupled to thermo-desorption gas chromatography-mass spectrometry (TD-GC-MS) analysis of the volatile constituents from beetles or turtle nests revealed 24 potential compounds. However, electroantennographic (EAG) measurements revealed antennal sensitivity only to indole, linoleic acid, trimethylamine, dimethyl sulphide, dimethyl disulphide and ammonia. Behavioural tests showed that these compounds are highly attractive to O. suberosus. Field trapping experiments revealed that indole and ammonia were more attractive than the other volatile compounds and showed similar attractiveness to that produced by conventional baits (chicken feathers). The use of a combined bait of indole and NH3 would therefore be the most effective trap design. The data presented are the first to demonstrate effective massive capture of O. suberosus using an attractant-based trapping method. These findings have potential for the development of an efficient mass trapping method for control of this beetle as part of efforts towards conservation of L. olivacea at La Escobilla in Oaxaca, Mexico.

Acorn consumption improves the immune response of the dung beetle Thorectes lusitanicus

Thorectes lusitanicus, a typically coprophagous species is also actively attracted to oak acorns, consuming, burying them, and conferring ecophysiological and reproductive advantages to both the beetle and the tree. In this study, we explored the possible relation between diet shift and the health status of T. lusitanicus using a generalist entomopathogenic fungus (Metarhizium anisopliae) as a natural pathogen. To measure the health condition and immune response of beetles, we analysed the protein content in the haemolymph, prophenoloxidase (proPO) content, phenoloxidase (PO) activity and mortality of beetles with diets based on either acorns or cow dung. Protein content, proPO levels and PO levels in the haemolymph of T. lusitanicus were found to be dependent on the type of diet. Furthermore, the beetles fed with acorns developed a more effective proPO-PO system than the beetles fed with cow dung. Furthermore, a significant decrease in mortality was observed when infected individuals were submitted to an acorn-based diet. In addition to enhancing an understanding of the relevance of dietary change to the evolutionary biology of dung beetles, these results provide a more general understanding of the ecophysiological implications of differential dietary selection in the context of fitness.

Abstract P6-04-07: Significance and therapeutic potential of PELP1-mTOR axis in breast cancer progression and therapy resistance

Proline, Glutamic-acid and Leucine-rich Protein 1 (PELP1) is a proto-oncogene that modulates ER signaling by functioning as an ER-coregulator. Emerging studies demonstrated that in a subset of breast tumors, PELP1 is predominantly localized in the cytoplasm and that PELP1 participates in extranuclear signaling by facilitating ER interactions with Src, PI3K, and AKT. PELP1 expression is upregulated in breast cancer, its deregulation contributes to therapy resistance, and PELP1 is a prognostic marker of poor survival. However, the mechanism by which PELP1 extranuclear actions contributes to cancer progression and therapy resistance remains unknown. We have recently discovered that PELP1 has the potential to interact with mammalian target of rapamycin (mTOR), a serine/threonine kinase that forms two distinct complexes called mTORC1 (containing Raptor and PRAS40) and mTORC2 (containing Rictor and Protor). The objective of this application is to test whether crosstalk occurs between mTOR and PELP1 signaling axis and to test whether mTOR targeting drugs can be used to target PELP1 oncogenic functions. We have used breast cancer cells with PELP1 overexpression (MCF7-PELP1, ZR75-PELP1, T47D-PELP1) or PELP1 down regulation (MCF7-PELP1shRNA, ZR75-PELP1shRNA) along with controls to study the role of PELP1 in the regulation of mTOR axis. PELP1 knockdown significantly reduced downstream mTOR signaling components as analyzed by Western analysis using phospho-S6K, -4EBP1, -mTOR and -Akt, antibodies. Overexpression of PELP1 activated mTOR signaling components. Using immunoprecipitation, we have demonstrated that PELP1 interacts with mTOR. Further immunopreciptation analysis using Rictor and Raptor specific antibodies revealed that PELP1 associates with both TORC1 and TORC2 complexes. Using PELP1WT and PELP1cyto (that predominantly localizes in the cytoplasm), we have demonstrated the differential activation of mTOR signaling components: PELP1WT activated both TORC1 and TORC2 pathways, while PELP1cyto uniquely activated TORC2. mTOR targeting drugs (Rapamycin or AZD8055) showed a significant effect on the in vitro proliferation of PELP1 model cells. AZD8055 is more potent in reducing PELP1 driven tumor growth in vivo compared to rapamycin. Immunohistochemical studies on xenografts derived from MCF7, MCF7-PELP1WT and MCF7-PELP1cyto models demonstrated that PELP1 signaling modulates mTOR signaling in vivo and inhibition of mTOR signaling rendered PELP1 driven tumors to be highly sensitive to therapeutic inhibition. Further, mTOR inhibitors sensitized tamoxifen therapy resistant PELP1cyto model cells to hormonal therapy. IHC analysis of mammary glands and mammary tumors from PELP1Tg mice revealed deregulation of mTOR signaling components with excessive activation of S6K and 4EBP1. Using breast tumor tissue arrays (n = 100), we found significant correlation of PELP1 cytosolic localization with mTOR signaling. Collectively, the experimental results from these studies identified PELP1-mTOR axis as a novel component of PELP1 oncogenic functions and suggests, mTOR inhibitor(s) will be effective chemotherapeutic agents for down regulating PELP1 oncogenic functions and for blocking PELP1-mediated therapy resistance.

Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P6-04-07.

Abstract P6-15-18: PELP1-KDM1 Axis: A Novel Therapeutic Target for Blocking Local Estrogen Synthesis

Background: Local estrogen production via deregulated expression of aromatase (Cyp19), the key enzyme in the biosynthesis of estrogen, contributes to tumor progression in post-menopausal women. Aromatase inhibitors (AI) are effective in enhancing patient survival although long term use is limited by systemic side effects and therapy resistance. Therefore, identifying novel pathways that contributes to in situ E2 in breast tumors and therapeutic agents to block these pathways are urgently needed. Recent studies from our lab demonstrated PELP1 proto-oncogene cooperates with HER2/neu and modulates epigenetic changes at aromatase promoter by interacting with lysine specific demethylase (KDM1) leading to local E2 synthesis. In this study, we examined the therapeutic efficacy of targeting the PELP-KDM1 axis in blocking local E2 production.

Methods: Three breast cancer model cells which exhibit local E2 were used: (a) MCF7 cells overexpressing HER2/neu onogene (MCF7-HER2), (b) MCF7 cells overexpressing proto-oncogene PELP1 (MCF7-PELP1), (c) MCF7 cells with acquired Letrozole resistance (MCF7-Ca-LTLT); parental MCF7 cells were used as controls. Therapeutic potential of KDM1 targeting drugs, (1) Pargyline, a monoamine oxidase inhibitor, (2) NCL-1, a KDM1-selective inhibitor to block PELP1-KDM1 axis were tested using proliferation, aromatase reporter, ChIP and RTqPCR assays. Efficacy of the KDM1 targeting drugs alone or in combination with Letrozole, and Dasatinib was also measured. Pre-clinical, post-memopausal nude mice based models were used to validate the drug effect in vivo.

Results: Depletion of PELP1 or KDM1 using siRNA substantially reduced proliferation of all three model cells and affected epigenetic modifications at the aromatase promoter. Reporter gene and ChIP assays showed growth factors and HER2/neu enhance PELP1 and KDM1 recruitment to the aromatase promoter. KDM1 inhibitors {pargyline (3mM) and NCL1 (10uM)} substantially inhibited growth of all three model cells. In postmenopausal xenograft based model, treatment with pargyline significantly inhibited the growth of local E2 producing tumor cells. IHC and ChIP analysis revealed alterations in histone methyl modifications in treated ER positive tumors. Combinatorial therapy of AI (Letrozole), Src kinaseinhibitor (Dasatinib) with Pargyline or NCL1 showed most promising therapeutic effect compared to single agent therapy to inhibit growth of therapy resistant cells.

Conclusions: Drugs targeting the PELP1-KDM1 are effective in reversing the methyl modifications at aromatase promoter that are affected by proto-oncogenes PELP1, HER2 and blocking growth of local E2 producing cells. Our results suggest targeting of PELP1-KDM1 axis in combination with current endocrine therapies will have a better therapeutic effect and may inhibit or delay development of AI resistance. This study is funded by Komen grant KG090447 and NIH grant CA095681.

Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P6-15-18.

Abstract P4-02-10: Significance of ER-Coregulator-Src Axis in Hormonal Resistance

Background: The estrogen receptor (ER) is implicated in the progression of breast cancer. Endocrine therapy using Tamoxifen, a selective estrogen receptor modulator (SERM), improves disease-free survival in postmenopausal women. Despite positive effects, initial or acquired resistance to endocrine therapies frequently occurs. Recent studies suggested the presence of alternative signaling pathways (including HER2 and c-Src kinase) that contribute to ER activation in the absence of estrogen. ER-coregulators play an essential role in hormonal responsiveness and coregulators such as PELP1 couples Src axis to ER thus representing a new pathway for targeted drug therapy. In this study, we examined the therapeutic efficacy of targeting the PELP-Src axis in blocking therapy resistance.

Methods: Three breast cancer model cell lines with resistance to Tamoxifen were used in this study: (1) MCF7-PELP1 (2) MCF7-HER2/neu and (3) MCF7-Tam. To establish the significance of ER-PELP1 coregulator-Src axis, we have generated additional model cells that stably express Src-ShRNA (MCF7-PELP1 -Src-shRNA and MCF7-HER2-SrcshRNA). Model cells were tested for proliferation using CellTiter-Glo assays, anchorage dependence and ER-extranuclear signaling by Western analysis using phospho-antibodies. Orally soluble Src inhibitor Dasatinib (SPRYCEL)was used to test whether it (a) blocks of ER-coactivator-Src signaling and (b) sensitizes the resistant breast cancer cells to endocrine therapy. Pre-clinical nude mice xenograft based studies were performed to validate the effect of Dasatinib alone or in combination with tamoxifen in vivo. IHC analysis of the tumors was performed to examine the effect of Dasatinib on ER signaling components.

Results: Src knock down or Dasatinib (100 nM) treatment substantially inhibited the growth of MCF7-PELP1, MCF7-HER2/neu and MCF7- Tam model cells in proliferation assays. Depletion of Src using siRNA substantially reduced E2 mediated activation of Src, MAPK and AKT in resistant model cells. In post-menopausal xenograft based studies, treatment with Dasatinib significantly inhibited the growth of therapy resistant cells. IHC analysis revealed that the tumors are ER positive, and Dasatinib (15 mg/kg/d) treated tumors exhibited alterations in Src and AKT pathways. Combinatorial therapy of Tamoxifen (100 μg/mouse/day) with Dasatinib showed better therapeutic effect compared to single agent therapy on the growth of therapy resistant tumors.

Conclusions: The results from this study showed that ER-PELP1 coregulator-Src axis play an important role in promoting hormonal resistance and blocking this axis prevents the development of hormonal independence in vivo. ER coregulator PELP1 and Src kinase are commonly deregulated in breast cancers therefore combination therapies using both endocrine agents and Dasatinib may have better therapeutic effect by delaying the development of hormonal resistance This study is supported by DOD grant W81XWH-08-1-0604.

Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P4-02-10.

Extranuclear signaling by estrogen: role in breast cancer progression and metastasis

The estrogen receptor (ERa) is implicated in the progression of breast cancer. Hormonal therapies which block ER functions or local and systemic estrogen production are currently used to treat ERa positive breast cancer. Hormonal therapy shows beneficial effects, however, initial or acquired resistance to endocrine therapies frequently occurs, and tumors recur as metastasis. Emerging evidence suggests in addition to exerting its well-studied nuclear functions, ERa also participates in extranuclear signaling that involve growth factor signaling components, adaptor molecules and the stimulation of cytosolic kinases. ERa extranuclear pathways have the potential to activate gene transcription, modulate cytoskeleton, and promote tumor cell proliferation, survival, and metastasis. Cytoplasmic/membrane ERa is detected in a subset of breast tumors and expression of extranuclear components ERa is deregulated in tumors. The extranuclear actions of ER are emerging as important targets for tumorigenic and metastatic control. Inhibition of ERa extranuclear actions has the potential to prevent breast tumor progression and may be useful in preventing ERa positive metastasis. In this review, we summarize the results of recent research into the role of ERa mediated extranuclear actions in breast tumorigenesis and metastasis.

Potential Role of Pargyline in Overcoming Adaptive Resistance in Breast Cancer Cells

Background: Estrogen-induced breast carcinogenesis is shown to be characterized by global changes in histone modifications. LSD1 (KDM1), a histone demethylase enzyme, play a key role in establishing specific histone methyl marks at target gene promoters. Recent evidence suggest that LSD1 is recruited to a significant fraction of estrogen receptor (ER) target genes and is required to demethylate proximal histones to enable productive ER transcription. These emerging findings also suggest that deregulation of LSD1 epigenetic pathway could contribute to hormonal independence and adaptive resistance in breast cancer cells. In this study, we examined the therapeutic efficacy of treating breast tumor cells with Pargyline, an FDA approved drug for blocking LSD1 functions, and evaluated the therapeutic benefit.Methods: To test this hypothesis, we used model cells that acquired resistance to hormonal therapy including (a) MCF7-HER2 that overexpress oncogene neu/HER2, (b) MCF7-Tam that have acquired resistance to Tamoxifen, (c) MCF7-Ca-LTLT cells that have acquired resistance to Letrozole, (d) MCF7 cells that overexpress proto-oncogene PELP1 (MCF7-PELP1). Parental MCF7 cells were used as a control. Cells were treated with LSD1 inhibitor Pargyline either alone or in combination with Letrozole and Dasatinib. Activation of ER genomic functions was studied using luciferase reporter gene assays. Epigenetic modifications at target promoters were analyzed by Chromatin immune precipitation (CHIP) assays using H3 methyl (di and Tri -H3K4, -K9) specific antibodies. Biological significance and hormonal therapy sensitivity was measured by in vitro cell proliferation assays. Xenograft studies were used to validate the drug effect in vivo. Pilot studies were performed for delivery of drug combinations using nanoparticle formulation.Results: Reporter gene assays showed that LSD1 has potential to enhance ER mediated transcription. LSD1 functionally interacts with ER coregulator PELP1 and is recruited to ER target genes. Pargyline substantially inhibited ER transactivation functions. ChIP analysis revealed that aggressively growing breast cancer cells and therapy resistant cells have distinct activating histone methyl modifications at growth regulatory ER target genes. Treatment of breast cancer models with LSD1 inhibitor Pargyline facilitated reversal of these specific modifications and thereby inhibited the growth of breast cancer cells in vitro and in vivo models. Combinatorial therapy using three agents; (a) that block Estrogen receptor genomic actions (Tamoxifen or Letrozole), (b) ER nongenomic actions (Dasatinib) and (c) ER epigenetic modifications (Pargyline) showed the most promising therapeutic effect compared to single agent therapy on the growth of therapy resistant cells.Conclusions: Our results suggest that histone methyl modification plays a role in therapy resistance and validates the therapeutic potential of Pargyline in combinational therapies. Collectively, these results suggest that targeting LSD1 axis with Pargyline in combination with current endocrine therapies will have better therapeutic effect and may inhibit or delay development of hormonal resistance, thus providing major benefits to patients care. This study is funded by Komen grant KG090447.

Citation Information: Cancer Res 2009;69(24 Suppl):Abstract nr 409.

Novel mouse model for studying role of ER-nongenomic actions in breast cancer

Abstract #601

Back ground: Estradiol (E2) and estrogen receptor (ER) signaling play a key role in development and progression of breast cancer. ER signaling is complex, involves coregulatory proteins and the status of ER coregulators in tumor cells plays an important role in hormonal responsiveness and tumor progression. In addition, ER also participates in non-genomic signaling events in the cytoplasm, however the significance of non-genomic signaling in mammary tumorigenesis remain unknown. PELP1/MNAR is novel ER coregulator that participates in ER genomic and non-genomic actions. PELP1 expression is deregulated in breast tumors and in a subset of tumors PELP1 is predominantly localized in the cytoplasm. Since PELP1 cytoplamsic localization promotes excessive activation of Src and AKT pathways, we hypothesized that PELP1 mediated excessive activation of ER-nongenomic functions may play a role tumorigenesis. To test this, we have generated MMTV-PELP1cyto TG model that uniquely express PELP1 in the cytoplasm of mammary glands that mimics the pathological situation of PELP1 localization seen breast cancer.
 Methods: As a means of targeting the expression of the PELP1 transgene to the mammary gland, we placed the PELP1cyto cDNA under the control of the MMTV promoter. PELP1 transgene integration was verified by PCR and expression levels by Western and IHC in each founder line. Whole-mount preparations and IHC analysis was performed using Tg and age controlled wild type littermates from different developmental stages. Total protein extracts of mammary gland were used for western blot analysis of nongenomic signaling components.
 Results: Preliminary analysis of mammary gland from PELP-cyto mice showed hyperplasia, increased proliferation as analyzed by PCNA staining. Mammary tumors were observed as early as 32 weeks. No spontaneous mammary tumors were found in the wild type cohort. Pathological analysis revealed that these tumor masses represent full blown mammary adenocarcinomas. Mammary tumors showed excessive activation of nongenomic signaling including activation of Src and AKT pathways. A clear induction of aromatase expression was found in PELP1 tumors compared with the wild-type that showed no aromatase expression in the mammary gland.
 Discussion: We have established and characterized a transgenic mouse model that mimics deregulated ER-nongenomic signaling. Our results suggest that PELP1 is a proto-oncogene and demonstrates its in vivo tumorigenic potential. PELP1 driven tumors are ER+ve, express aromatase, thus provide an interesting in vivo model for studying ER-mediated tumorigenesis and to study effect of local E2 on ER-mediated tumorigenesis.

Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 601.

Social cognitions as organizers of autonomic and affective responses to social challenge

Autonomic and affective responses to children were assessed as a function of adult perceptions of interpersonal control. Women (N = 160) interacted with and provided feedback to computer-simulated children who "behaved" responsively or unresponsively on a computer game. Women were categorized as low in perceived control (PC) if they attributed high control to children but low control to self over negative events on the Parent Attribution Test. As predicted, low-PC women were maximally reactive to child characteristics, manifesting peak levels of defensive arousal (increased level of heart rate and electrodermal activity) and negative affect with unresponsive children and minimal levels of arousal and negative affect with responsive children. Intermediate response levels were shown by high-PC Ss. We interpreted results as suggesting mediating factors that may operate in dysfunctional interaction patterns previously found for low-PC caregivers.

Social cognitions as organizers of autonomic and affective responses to social challenge

Autonomic and affective responses to children were assessed as a function of adult perceptions of interpersonal control. Women (N = 160) interacted with and provided feedback to computer-simulated children who "behaved" responsively or unresponsively on a computer game. Women were categorized as low in perceived control (PC) if they attributed high control to children but low control to self over negative events on the Parent Attribution Test. As predicted, low-PC women were maximally reactive to child characteristics, manifesting peak levels of defensive arousal (increased level of heart rate and electrodermal activity) and negative affect with unresponsive children and minimal levels of arousal and negative affect with responsive children. Intermediate response levels were shown by high-PC Ss. We interpreted results as suggesting mediating factors that may operate in dysfunctional interaction patterns previously found for low-PC caregivers.

Influences of witnessed affect on information processing in children

Children between the ages of 5 and 10 years watched a videotape of a child having a routine medical exam. Embedded within the scenes were systematic variations of depicted facial affect shown by doctor and child. Measures were taken of autonomic reactions and information-processing errors in response to positive, neutral, and negative affective cues. For 5-6-year-olds, processing errors were greatest in the negative affect condition. Additionally, peak increases in heart rate (HR) and skin conductance level (SCL) were demonstrated by 5-6-year-olds in response to negative affect shown by the witnessed child; increases in HR were in turn predictive of processing errors. Older children (9-10 years) showed trends reflecting reduced processing errors in response to witnessed negative affect. It was suggested that younger children respond to salient threat cues with a "defensive" response pattern that is relatively adaptive at younger but not older ages.